MBRX Moleculin Biotech, Inc. - Common Stock
NASDAQ · Biotechnology · Visualizza su SEC EDGAR ↗ chiudi Ott 2, 2026 10-K/10-Q Ago 13, 2026
$0,49
· % dell'intervallo 52 sett.
· sopra il minimo
· al massimo
$0,16minimo 52 sett.
$12,65massimo 52 sett.
Capitalizzazione di Mercato (MRQ)
$3M
Ricavi
$0
i tuoi badge
Intervallo 52 sett.
$0–$13
Rating Analisti
BUY
Prezzo Obiettivo
$12
P/E
·
ROE
·
Margine di Profitto Netto
·
La tua barra dei badge è vuota — aggiungi una metrica a piacere in questa pagina.
MBRX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$0.49
Capitalizzazione di Mercato (MRQ)
$3M
Ricavi
$0
Intervallo 52 sett.
$0–$13
MBRX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
intervallo
barre
La granularità delle barre si adatta al periodo selezionato — passa il mouse sul grafico per vedere apertura/massimo/minimo/chiusura di una barra.
Split azionari
| Data ex-dividendo | Split | Tipo |
|---|---|---|
| 01 Dicembre 2025 | 1-for-25 | Inverso |
| 22 Marzo 2024 | 1-for-15 | Inverso |
| 01 Febbraio 2021 | 1-for-6 | Inverso |
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi$02016-12-31 → 2025-12-31
Flusso di cassa libero·2016-12-31 → 2022-12-31
Valutazione e Rapporti
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
| Metrica | Tendenza 5 anni | MBRX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| P/B (MRQ) | 0.3 | · | 1.5 | Valore equo | |
| Price / Tangible Book (Prezzo / Valore contabile tangibile) | 0.7media 5 anni ≈3.1 | ≈3.1 | · | · |
La mediana dei peer viene calcolata su base standardizzata per metrica e potrebbe non corrispondere sempre alla base TTM/MRQ mostrata per questo titolo.
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
| Metrica | Tendenza 5 anni | MBRX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Rapporto corrente (MRQ) | 0.9 | · | 3.8 | Bassa liquidità |
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Nessun dato per questo gruppo di rapporti al momento
Dati fondamentali insufficienti per calcolare questo gruppo di rapporti.
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
| Metrica | Tendenza 5 anni | MBRX | media 5 anni | Mediana dei peer | Verdetto |
|---|---|---|---|---|---|
| Revenue / Employee (Ricavi / Dipendente) | ≈$0.00 | · | · | · |
valore · ≈ media 5 anni · mediana del settore · giudizio rispetto alla mediana
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-1.8%
Prossimo report
Nov 11, 2026
| Periodo | Rapporto | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|---|
| 30 Giugno 2026 | Ago 13, 2026 | $-1.40 | $-1.58 | 11.6% |
| 31 Marzo 2026 | Mag 14, 2026 | $-3.54 | $-1.70 | -108.7% |
| 31 Dicembre 2025 | $13.04 | $-6.24 | 309.1% | |
| 30 Settembre 2025 | $-17.00 | $-4.97 | -241.9% | |
| 30 Giugno 2025 | $-12.25 | $-9.26 | -32.2% | |
| 31 Marzo 2025 | $-17.25 | $-14.15 | -21.9% | |
| 31 Dicembre 2024 | $-9.32 | $-32.72 | 71.5% |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $16M | $18M | $19M | $19M | $14M | $13M | $11M | $10M | $5M | $1M | |
| SG&A Expense | $9M | $9M | $10M | $12M | $8M | $7M | $6M | $5M | $4M | $2M | |
| Operating Expenses | $25M | $27M | $30M | $31M | $23M | $20M | $18M | $15M | $9M | $4M | |
| Operating Income | $-25M | $-27M | $-30M | $-31M | $-23M | $-20M | $-18M | $-15M | $-9M | $-4M | |
| Interest Expense | · | · | · | · | · | · | · | · | $0 | $43.0K | |
| Other Non-op | $-20.0K | $43.0K | $48.0K | $40.0K | $40.0K | $28.0K | $15.0K | $-40.0K | $9.0K | · | |
| Pretax Income | $-34M | $-26M | · | · | · | $-17M | $-13M | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $-229.0K | $0 | $0 | $0 | |
| Net Income | $-34M | $-26M | $-30M | $-29M | $-16M | $-17M | $-13M | $-12M | $-10M | $-4M | |
| EPS (Basic) | $-28.42 | $-189.14 | $-15.07 | $-15.22 | $-0.59 | · | · | · | · | · | |
| Shares (Basic) | 1,184,569 | 137,720 | 1,975,610 | 1,906,960 | 26,875,927 | · | · | · | · | · | |
| EBITDA | · | · | · | $-31M | $-23M | $-20M | $-17M | $-15M | $-9M | $-4M |
Stato Patrimoniale
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $4M | $24M | $43M | $71M | $15M | $11M | $7M | $8M | $5M | |
| Receivables | · | · | · | · | · | · | $1.0K | $56.0K | · | · | |
| Prepaid Expense | $808.0K | $916.0K | $3M | $2M | $2M | $2M | $3M | $840.0K | $588.0K | $215.0K | |
| Other Current Assets | · | · | · | · | · | · | $529.0K | · | · | · | |
| Current Assets | $10M | $5M | $26M | $46M | $72M | $17M | $13M | $8M | $8M | $5M | |
| PP&E (Net) | $78.0K | $159.0K | $272.0K | $275.0K | $338.0K | $483.0K | $316.0K | $463.0K | $33.0K | $23.0K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | $57.0K | · | |
| Accum. Depreciation | $1M | $1M | $896.0K | $769.0K | · | $474.0K | $284.0K | $93.0K | $21.0K | $6.0K | |
| Other Non-current Assets | $900.0K | $0 | · | · | · | · | · | · | · | · | |
| Total Assets | $22M | $17M | $38M | $57M | $84M | $29M | $25M | $20M | $19M | $16M | |
| Accounts Payable | $4M | $2M | $2M | $2M | $1M | $1M | $2M | $1M | $810.0K | $399.0K | |
| Accrued Liabilities | $3M | $3M | $4M | $3M | $2M | $2M | $1M | $2M | $902.0K | $650.0K | |
| Current Liabilities | $7M | $5M | $7M | $5M | $4M | $3M | $4M | $4M | $2M | $1M | |
| Capital Leases | $222.0K | $358.0K | $474.0K | $335.0K | $63.0K | $159.0K | $276.0K | · | · | · | |
| Total Liabilities | $7M | $6M | $12M | $5M | $5M | $11M | $10M | $5M | $2M | $1M | |
| Common Stock | $3.0K | $0 | $33.0K | $29.0K | $29.0K | $69.0K | $46.0K | $29.0K | $21.0K | $12.0K | |
| Retained Earnings | $-206M | $-172M | $-132M | $-102M | $-73M | $-57M | $-40M | $-26M | $-14M | $-5M | |
| AOCI | $10.0K | $-41.0K | · | · | · | · | · | · | $0 | · | |
| Stockholders' Equity | $15M | $11M | $31M | $52M | $79M | $18M | $16M | $14M | $17M | $15M | |
| Liabilities + Equity | $22M | $17M | $38M | $57M | $84M | $29M | $25M | $20M | $19M | $16M | |
| Shares Outstanding | 3,199,228 | 135,155 | 2,227,516 | 1,908,523 | 28,578,338 | 11,536,720 | 7,621,338 | 28,528,663 | 21,469,109 | 12,164,852 |
Flusso di cassa
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $90.0K | $126.0K | $127.0K | $130.0K | $164.0K | $200.0K | $199.0K | $68.0K | $18.0K | $6.0K | |
| Stock-based Comp | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $707.0K | $324.0K | |
| Deferred Tax | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Other Non-cash | · | · | · | $-1M | $-6M | $-2M | $-6M | $-2M | $2M | $-168.7K | |
| Operating Cash Flow | $-23M | $-24M | $-24M | $-28M | $-19M | $-18M | $-17M | $-12M | $-7M | $-4M | |
| CapEx | $0 | $13.0K | $124.0K | $67.0K | $19.0K | $376.0K | $52.0K | $417.0K | $28.0K | $21.0K | |
| Investing Cash Flow | $0 | $-13.0K | $-124.0K | $-67.0K | $-19.0K | $-374.0K | $-51.0K | $-417.0K | $-28.0K | $-121.0K | |
| Stock Issued | · | · | · | $0 | $75M | $23M | $19M | · | · | · | |
| Net Stock Activity | · | · | · | $0 | $75M | $23M | · | · | · | · | |
| Financing Cash Flow | $27M | $5M | $4M | $-23.0K | $75M | $23M | $21M | $12M | $10M | $9M | |
| Net Change in Cash | $5M | $-19M | $-20M | $-28M | $56M | $4M | $4M | $-580.0K | $3M | $5M | |
| Taxes Paid | $0 | $0 | · | · | $15.0K | $24.0K | $19.0K | $21.0K | $0 | $0 | |
| Free Cash Flow | · | · | · | $-28M | $-19M | $-18M | $-17M | $-13M | $-7M | $-4M |
Redditività
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | · | · | · | -41.0% | -28.1% | -64.0% | -58.9% | -60.8% | -54.7% | -47.8% | |
| ROE | · | · | · | -52.5% | -19.8% | -107.7% | -76.4% | -81.2% | -61.1% | -55.2% | |
| ROIC | · | · | · | · | · | -111.2% | · | · | · | · |
Liquidità e Solvibilità
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | · | · | 9.5 | 20.0 | 5.9 | 3.8 | 2.1 | 3.7 | 3.9 | |
| Quick Ratio | · | · | · | 9.0 | 19.6 | 5.2 | 3.0 | 1.8 | 3.5 | 3.7 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -89.9 |
Efficienza
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | · | · | · | 0.0 | · | · | · |
Per Azione
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | · | · | · | $2.76 | $1.54 | $0.34 | $0.50 | $0.80 | $1.23 | |
| Cash / Share | · | · | · | · | $2.48 | $1.32 | $0.23 | $0.25 | $0.36 | $0.41 |
Valutazione (TTM)
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-34M | $-26M | $-30M | $-29M | $-16M | $-17M | $-13M | $-12M | $-10M | $-4M | |
| Market Cap | · | · | · | · | $797M | $828M | $3.77B | $2.67B | $3.59B | $2.50B | |
| P/B | · | · | · | · | 10.1 | 46.6 | 241.8 | 187.1 | 210.0 | 166.9 | |
| P / Tangible Book | 0.7 | 0.5 | 0.9 | · | 10.1 | 46.6 | · | · | · | · | |
| P / Cash Flow | · | · | · | · | -42.1 | -46.6 | -219.0 | -218.8 | -490.7 | -663.0 | |
| P / FCF | · | · | · | · | -42.0 | -45.6 | -218.3 | -211.6 | -488.8 | -659.3 |
Conto Economico
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $5M | $5M | $5M | $4M | $4M | $3M | $4M | $5M | $4M | $4M | $7M | $3M | $4M | $6M | $4M | $6M | |
| SG&A Expense | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $3M | $3M | $3M | |
| Operating Expenses | $8M | $8M | $8M | $6M | $6M | $6M | $7M | $7M | $6M | $7M | $9M | $6M | $6M | $8M | $7M | $9M | |
| Operating Income | $-8M | $-8M | $-8M | $-6M | $-6M | $-6M | $-7M | $-7M | $-6M | $-7M | $-9M | $-6M | $-6M | $-8M | $-7M | $-9M | |
| Other Non-op | $13.0K | $76.0K | $-49.0K | $16.0K | $4.0K | $9.0K | $12.0K | $9.0K | $11.0K | $11.0K | $18.0K | $13.0K | $9.0K | $8.0K | $1.0K | $19.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-8M | $-13M | $16M | $-25M | $-18M | $-6M | $-7M | $-7M | $-6M | $-6M | $-10M | $-6M | $-6M | $-8M | $-7M | $-9M | |
| EPS (Basic) | $-1.40 | $-3.54 | $-25.96 | $-0.68 | $-28.68 | $-15.80 | $-182.27 | $-1.89 | $-2.37 | $-2.61 | $-5.10 | $-2.82 | $-3.02 | $-4.13 | $-14.44 | $-0.30 | |
| Shares (Basic) | 5,680,717 | 4,124,482 | · | 37,304,455 | 621,056 | 373,751 | · | 3,714,278 | 2,543,244 | 2,466,174 | · | 1,987,283 | 1,979,258 | 1,916,665 | · | 28,627,610 | |
| EBITDA | $-8M | $-8M | · | $-6M | $-6M | $-6M | · | $-7M | $-6M | $-7M | · | $-6M | $-6M | $-8M | · | $-9M |
Stato Patrimoniale
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $10M | $9M | $7M | $8M | $8M | $4M | $9M | $11M | $17M | $24M | $25M | $32M | $37M | $43M | $50M | |
| Prepaid Expense | $1M | $644.0K | $808.0K | $1M | $2M | $2M | $916.0K | $2M | $3M | $2M | $3M | $3M | $3M | $2M | $2M | $3M | |
| Current Assets | $9M | $11M | $10M | $8M | $9M | $9M | $5M | $12M | $14M | $19M | $26M | $28M | $35M | $39M | $46M | $53M | |
| PP&E (Net) | $62.0K | $70.0K | $78.0K | $77.0K | $99.0K | $127.0K | $159.0K | $190.0K | $221.0K | $240.0K | $272.0K | $225.0K | $229.0K | $244.0K | $275.0K | $306.0K | |
| Accum. Depreciation | · | · | $1M | · | · | · | $1M | · | · | · | $896.0K | · | · | · | $769.0K | · | |
| Other Non-current Assets | $900.0K | $900.0K | $900.0K | $900.0K | $900.0K | · | $0 | · | · | · | · | · | · | · | · | · | |
| Total Assets | $21M | $23M | $22M | $20M | $22M | $21M | $17M | $23M | $26M | $31M | $38M | $40M | $47M | $51M | $57M | $65M | |
| Accounts Payable | $4M | $5M | $4M | $2M | $4M | $3M | $2M | $3M | $3M | $2M | $2M | $2M | $4M | $2M | $2M | $4M | |
| Accrued Liabilities | $5M | $3M | $3M | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $4M | $2M | $2M | $3M | $3M | $3M | |
| Current Liabilities | $9M | $8M | $7M | $6M | $8M | $7M | $5M | $6M | $6M | $5M | $7M | $4M | $7M | $5M | $5M | $6M | |
| Capital Leases | $147.0K | $185.0K | $222.0K | $258.0K | $292.0K | $326.0K | $358.0K | $390.0K | $420.0K | $450.0K | $474.0K | $496.0K | $291.0K | $308.0K | $335.0K | $365.0K | |
| Total Liabilities | $10M | $8M | $7M | $47M | $29M | $21M | $6M | $16M | $8M | $9M | $12M | $4M | $7M | $5M | $5M | $7M | |
| Common Stock | $7.0K | $5.0K | $3.0K | $49.0K | $30.0K | $14.0K | $0 | $3.0K | $3.0K | $2.0K | $33.0K | $30.0K | $30.0K | $30.0K | $29.0K | $29.0K | |
| Retained Earnings | $-226M | $-219M | $-206M | $-222M | $-167M | $-160M | $-172M | $-151M | $-141M | $-137M | $-132M | $-121M | $-116M | $-110M | $-102M | $-95M | |
| AOCI | $-64.0K | $-52.0K | $10.0K | · | · | · | $-41.0K | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $12M | $15M | $15M | $-27M | $-7M | $42.0K | $11M | $7M | $18M | $22M | $26M | $35M | $40M | $46M | $52M | $58M | |
| Liabilities + Equity | $21M | $23M | $22M | $20M | $22M | $21M | $17M | $23M | $26M | $31M | $38M | $40M | $47M | $51M | $57M | $65M | |
| Shares Outstanding | 7,100,000 | 5,336,350 | 3,199,228 | 49,498,576 | 30,207,494 | 14,127,494 | 135,155 | 3,001,895 | 2,560,785 | 2,311,536 | 2,227,516 | 29,810,443 | 29,789,322 | 29,600,323 | 1,908,523 | 28,627,827 |
Flusso di cassa
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8.0K | $8.0K | $9.0K | $21.0K | $29.0K | $31.0K | $32.0K | $31.0K | $31.0K | $32.0K | $34.0K | $32.0K | $31.0K | $30.0K | $32.0K | $32.0K | |
| Stock-based Comp | $436.0K | $380.0K | $459.0K | $303.0K | $417.0K | $485.0K | $427.0K | $353.0K | $453.0K | $493.0K | $479.0K | $493.0K | $513.0K | $499.0K | $535.0K | $699.0K | |
| Other Non-cash | · | $6M | · | · | · | $1M | · | · | · | $-2M | · | · | · | $1M | · | · | |
| Operating Cash Flow | $-7M | $-6M | $-5M | $-7M | $-6M | $-5M | $-5M | $-6M | $-6M | $-7M | $-5M | $-8M | $-5M | $-6M | $-7M | $-8M | |
| CapEx | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $13.0K | $0 | $81.0K | $28.0K | $15.0K | $0 | $0 | $0 | |
| Investing Cash Flow | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $-13.0K | $0 | $-81.0K | $-28.0K | $-15.0K | $0 | $0 | $0 | |
| Stock Issued | · | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $70.0K | $141.0K | · | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $141.0K | · | · | |
| Financing Cash Flow | $4M | $8M | $7M | $6M | $5M | $8M | $1.0K | $5M | $-25.0K | $0 | $4M | $-4.0K | $49.0K | $141.0K | $0 | $-11.0K | |
| Net Change in Cash | $-3M | $1M | $2M | $-854.0K | $-159.0K | $3M | $-5M | $-1M | $-6M | $-7M | $-1M | $-8M | $-5M | $-6M | $-7M | $-8M | |
| Free Cash Flow | · | · | · | · | · | $-5M | · | · | · | · | · | · | · | $-6M | · | · |
Redditività
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -35.8% | -57.9% | · | -116.1% | -32.4% | -24.8% | · | -33.7% | -11.9% | -12.1% | · | -10.7% | -9.9% | -12.2% | · | -11.2% | |
| ROE | -345.3% | -168.7% | · | 261.3% | -145.0% | -59.5% | · | -49.7% | -14.9% | -14.8% | · | -12.0% | -11.2% | -13.4% | · | -12.3% |
Liquidità e Solvibilità
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.9 | 1.4 | · | 1.4 | 1.1 | 1.4 | · | 2.1 | 2.4 | 3.5 | · | 7.1 | 5.4 | 7.8 | · | 8.4 | |
| Quick Ratio | 0.8 | 1.3 | · | 1.2 | 1.0 | 1.1 | · | 1.7 | 1.9 | 3.1 | · | 6.3 | 4.9 | 7.4 | · | 7.9 |
Efficienza
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Per Azione
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.63 | $2.85 | · | $-0.54 | $-0.24 | $0.00 | · | $2.49 | $6.91 | $9.34 | · | $1.18 | $1.35 | $1.54 | · | $2.04 | |
| Cash / Share | $1.02 | $1.93 | · | $0.14 | $0.25 | $0.55 | · | $3.13 | $4.24 | $7.28 | · | $0.82 | $1.08 | $1.26 | · | $1.76 |
Valutazione (TTM)
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | |
| Net Income TTM | $-30M | $-41M | · | $-56M | $-37M | $-26M | · | $-30M | $-28M | $-28M | · | $-26M | $-29M | $-30M | · | $-25M | |
| Market Cap | $20M | $12M | · | $26M | $9M | $14M | · | $9M | $9M | $14M | · | $191M | $259M | $426M | · | $455M | |
| P/B | 1.7 | 0.8 | · | -1.0 | -1.3 | 327.6 | · | 1.1 | 0.5 | 0.6 | · | 5.4 | 6.4 | 9.3 | · | 7.8 | |
| P / Tangible Book | 1.7 | 0.8 | · | · | · | 327.6 | · | 1.1 | 0.5 | 0.6 | · | 5.4 | 6.4 | 9.3 | · | 7.8 | |
| P / Cash Flow | · | -2.0 | · | · | · | -3.0 | · | · | · | -2.0 | · | · | · | -70.8 | · | · |
Periodo più recente a sinistra · valori nulli mostrati come ·
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Ricavi | $0 | $0 | $0 | $0 | $0 |
| Utile netto | $-34M | $-26M | $-30M | $-29M | $-16M |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Rapporto corrente | · | · | · | 9.5 | 20.0 |
| Quick Ratio | · | · | · | 9.0 | 19.6 |
| Metrica | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Flusso di cassa libero | · | · | · | $-28M | $-19M |
Proprietari istituzionali (13F) 20 filer · $570K totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Detentori
20
Valore detenuto
$570K
Nuove posizioni
5
Posizioni chiuse
7
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 5 (-2 vs trimestre precedente) | 7 (+4 vs trimestre precedente) | 7 (+3 vs trimestre precedente) | 0 (-2 vs trimestre precedente) | +34K |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | $131.832 | 47.252 | 23,13% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $117.780 | 42.215 | 20,66% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $83.374 | 29.883 | 14,63% | Azioni |
| XTX Topco Ltd | $64.008 | 22.942 | 11,23% | Azioni |
| MORGAN STANLEY | $55.901 | 20.036 | 9,81% | Azioni |
| VANGUARD GROUP INC | $51.450 | 15.544 | 9,03% | Azioni |
| Rockefeller Capital Management L.P. | $41.850 | 15.000 | 7,34% | Azioni |
| Tower Research Capital LLC (TRC) | $9.804 | 3.514 | 1,72% | Azioni |
| CITIGROUP INC | $7.460 | 2.674 | 1,31% | Azioni |
| BARCLAYS PLC | $1.733 | 621 | 0,30% | Azioni |
| BlackRock, Inc. | $1.370 | 491 | 0,24% | Azioni |
| EFG International AG | $1.211 | 434 | 0,21% | Azioni |
| JONES FINANCIAL COMPANIES LLLP | $1.177 | 360 | 0,21% | Azioni |
| WELLS FARGO & COMPANY/MN | $558 | 200 | 0,10% | Azioni |
| NFSG Corp | $318 | 114 | 0,06% | Azioni |
| SBI Securities Co., Ltd. | $123 | 44 | 0,02% | Azioni |
| Sandy Spring Bank | $87 | 89 | 0,02% | Azioni |
| DANSKE BANK A/S | $6 | 2 | 0,00% | Azioni |
| CVA Family Office, LLC | $3 | 1 | 0,00% | Azioni |
| OSAIC HOLDINGS, INC. | $2 | 1 | 0,00% | Azioni |
Attivisti e proprietari del 5%+ 2 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Foster Jonathan P. | 25 Agosto 2026 | 6,30% | Deposito iniziale | Investimento passivo | SEC |
| AnnaMed, Inc., KLEMP WALTER V | 25 Agosto 2026 | 9,90% | Deposito iniziale | Investimento passivo | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insider aziendali 10 insider · 3 dirigenti · 7 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Walter V Klemp | CEO and President | 03 Agosto 2026 A | 564.340 | 0 | 0 | $0 |
| Jonathan P. Foster | Chief Financial Officer | 03 Agosto 2026 P | 305.673 | 0 | 0 | $0 |
| Donald H Picker | Chief Science Officer | 03 Agosto 2026 P | 174.086 | 0 | 0 | $0 |
| Joy Yan | Direttore | 12 Novembre 2025 A | · | 0 | 0 | $0 |
| Robert E. George | Direttore | 12 Novembre 2025 A | 14.660 | 0 | 0 | $0 |
| John M Climaco | Direttore | 12 Novembre 2025 A | · | 0 | 0 | $0 |
| Elizabeth Cermak | Direttore | 12 Novembre 2025 A | · | 0 | 0 | $0 |
| Michael D Cannon | Direttore | 12 Novembre 2025 A | · | 0 | 0 | $0 |
| Jacqueline Northcut | Direttore | 05 Maggio 2017 P | 1.000 | 0 | 0 | $0 |
| Waldemar Priebe | Proprietario del 10% | 20 Agosto 2020 A | 2.781.573 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Proprietà ETF Posseduto da 1 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 42.215 SH | 19 Agosto 2026 | Giornaliero |
MBRX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
rating · 9 analisti
COMPRA
Target mediano
$3.00
+516,3%
2 22,2%
Acquisto forte
6 66,7%
Compra
1 11,1%
Mantieni
0 0,0%
Vendi
0 0,0%
Vendita forte
Target Price a 12 Mesi
3 analisti · 2026-09-29Target medio $12.00 +2365,1%
← Sotto tutti i target
Prezzo attuale $0.49
Basso$2.00
Media$12.00
Alto$31.00
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
Base FY, prezzi alla chiusura dell'ultimo anno fiscale di ciascuna società.
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
Scegli le metriche che contano per te: fai clic sul + accanto a qualsiasi riga in Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Fonte: SEC 10-Q depositato Ago 13, 2026